Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,6277 USD | +3,41% | +2,07% | -53,50% |
Omzet 2024 * | 3K 2,81K | Omzet 2025 * | 2,5 mln. 2,34 mln. | Marktkapitalisatie | 22,52 mln. 21,07 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -68 mln. -63,6 mln. | Nettowinst (verlies) 2025 * | -77 mln. -72,02 mln. | EV/omzet 2024 * | 7.508 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 9 x |
K/w-verhouding 2024 * |
-0,43
x | K/w-verhouding 2025 * |
-0,49
x | Werknemers | 58 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,11% |
Recentste transcriptie over Biora Therapeutics, Inc.
1 dag | +3,41% | ||
1 week | +2,07% | ||
Lopende maand | -42,94% | ||
1 maand | -52,80% | ||
3 maanden | -33,22% | ||
6 maanden | -67,97% | ||
Lopend jaar | -53,50% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Adi Mohanty
CEO | Chief Executive Officer | 57 | 08-11-21 |
Eric d'Esparbes
DFI | Director of Finance/CFO | 56 | 01-05-19 |
Ariella Kelman
CTO | Chief Tech/Sci/R&D Officer | - | 01-05-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 49 | 01-06-14 | |
Jeffrey Alter
CHM | Chairman | 61 | 01-01-19 |
Adi Mohanty
CEO | Chief Executive Officer | 57 | 08-11-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 0,6277 | +3,41% | 133 686 |
25-04-24 | 0,607 | -2,08% | 151 521 |
24-04-24 | 0,6199 | -2,99% | 184 411 |
23-04-24 | 0,639 | +5,43% | 383 304 |
22-04-24 | 0,6061 | -1,45% | 160 218 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-53,50% | 22,52 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |